Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
acetylon pharmaceuticals
ambys medicines
biotech
boston blog main
boston top stories
cell therapy
constellation pharmaceuticals
deals
gene therapy
genentech
holger willenbring
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
life sciences
liver disease
markus grompe
martin burke
national blog main
national top stories
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
salk institute for biological studies
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
startups
takeda
third rock ventures
ucsf
university of illinois urbana-champaign
vc
warp drive bio
What
big
2
×
deal
2
×
startup
today
2
×
actually
aiming
ambys
associated
based
biotech
blood
called
cancer
cancers
catch
claims
continue
control
data
deadly
debuted
detect
diego
diseases
doesn’t
early
evidence
finds
formed
future
genomics
launch
liver
make
medicine
medicines
multiple
mutations
new
pathway
Language
Current search:
big
×
today
×
deal
×
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@theverge.com
8 years ago
Startup claims its test finds cancer early, but where’s the evidence?
